| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/26/2000 | EP0554381B2 Use of protective agents against reactive oxygen species |
| 04/26/2000 | EP0554247B1 Neuroprotective indolone and related derivatives |
| 04/26/2000 | CN1251589A Substituted triazolo-pyridazine derivatives as ligands for GABA receptors |
| 04/26/2000 | CN1251530A Use of substaces having oxytocin activity for preparation of medicaments for wound healing |
| 04/26/2000 | CN1251526A New therapeutic combinations of mirtazapine and antipsychotic agents, for treatment of prophylaxis of psychotic disorders |
| 04/26/2000 | CN1251521A Compound and method for therapeutic intervention in preventing diabetic complications |
| 04/26/2000 | CN1051758C Anti-androgenic cyclo and bicycle alkenes |
| 04/26/2000 | CN1051705C Composition comprising tramadol material and any of codeine, oxycodone or hydrocodone and their use thereof |
| 04/25/2000 | US6054614 Process for the preparation of tetralone imines for the preparation of active pharmaceutical compounds |
| 04/25/2000 | US6054588 Heterocyclic vinyl ethers |
| 04/25/2000 | US6054482 Hydrolysis of gabapentin or the lactam to form acid addition salt, conversion to pure compound by ion exchanging; antiepileptic agents |
| 04/25/2000 | US6054474 Activating opioid receptors |
| 04/25/2000 | US6054469 Treatment of migraine and associated conditions. |
| 04/25/2000 | US6054464 Azabicyclic esters of carbamic acids useful in therapy |
| 04/25/2000 | US6054460 Anticonvulsive and antiallergic/antiasthmatic pyrazolo-[3,4-d]pyrimidines, and process for preparing |
| 04/25/2000 | US6054452 N-oxides of heterocyclic esters, amides, thioesters, and ketones |
| 04/25/2000 | US6054448 2-amino-2-(3-substituted cyclobutyl) acetic acid derivatives |
| 04/25/2000 | US6054430 Substantially free of species having a molecular weight of over 40 kilodaltons; trifluoroacetyl copolymer-1 treated with hbr. |
| 04/25/2000 | US6054293 Polypeptide involved in chemotatic response; screening for modulator proteins involved in nerve cell migration |
| 04/25/2000 | US6054127 A therapeutic treatment for cocaine addiction; the conjugate capable of stimulating the production of anti-hapten antibodies; a therapeutic immunization regimen elicits anti-drug antibodies |
| 04/25/2000 | US6054115 Purifying by exposing a mixture of uncoordinated hydroxyalkyl phosphine groups and coordinated hydroxyalkyl phosphine groups to an amine to separate the unbound coordinated groups from the bound uncoordinated groups |
| 04/25/2000 | CA2105575C Esters of bi- and tricyclic amino alcohols, their preparation and their use in pharmaceutical compositions |
| 04/25/2000 | CA2045453C Condensed heterocyclic compound and psychopharmaceutical composition containing same |
| 04/23/2000 | CA2287562A1 Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction |
| 04/23/2000 | CA2287105A1 Crystalline form of nefazodone and process for the preparation thereof |
| 04/20/2000 | WO2000023431A1 Method for the preparation of citalopram |
| 04/20/2000 | WO2000022142A2 Cell signaling polypeptides and nucleic acids |
| 04/20/2000 | WO2000022126A1 Follistatin-related protein zfsta2 |
| 04/20/2000 | WO2000022118A2 Non-desensitizing ampa-receptors |
| 04/20/2000 | WO2000022113A1 ENZYMATIC SYNTHESIS OF ssDNA |
| 04/20/2000 | WO2000021996A2 Methods and compositions for inhibiting neoplastic cell growth |
| 04/20/2000 | WO2000021978A2 Laminin 5, 13 and 14 and uses thereof |
| 04/20/2000 | WO2000021977A1 Pregnane glucuronides |
| 04/20/2000 | WO2000021964A1 Imidazo-benzazepines having cardiovascular, antitumor, antiinfective and anfiinflammatory activity |
| 04/20/2000 | WO2000021963A1 Il-8 receptor antagonists |
| 04/20/2000 | WO2000021961A1 Imidazo-isoquinoline compounds, their compositions and uses |
| 04/20/2000 | WO2000021953A1 Aryl-{4-fluoro-4-[(2-pyridin-2-yl-ethylamino)-methyl]-piperidin-1-yl}-methanone derivatives as 5-ht1 receptor antagonists |
| 04/20/2000 | WO2000021951A1 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents) |
| 04/20/2000 | WO2000021950A1 2,3-dihydro-1h-isoindole derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents) |
| 04/20/2000 | WO2000021931A1 Ureidopiperidine derivatives as selective human nk3 receptor antagonists |
| 04/20/2000 | WO2000021930A1 Esters of (+)-alpha-( 2,3- dimethoxyphenyl) -1-[2-(4- fluorophenyl) ethyl]-4- piperidinemethanol and their use as prodrugs of the 5ht2a receptor antagonist mdl 110,907 |
| 04/20/2000 | WO2000021927A2 Pyrrole-2,5-diones as gsk-3 inhibitors |
| 04/20/2000 | WO2000021920A1 Diaminopropionic acid derivatives |
| 04/20/2000 | WO2000021562A1 Method to prevent xenograft transplant rejection |
| 04/20/2000 | WO2000021535A1 Pharmaceutical formulations for use in estrogen deprivation syndrome |
| 04/20/2000 | WO2000021534A1 Pharmaceutical combination of ibuprofen-lysine and domperidone for treating migraine |
| 04/20/2000 | WO2000021526A1 Combination of carnitines and resveratrol for prevention or treatment of cerebral and ageing disorders |
| 04/20/2000 | WO2000021525A2 Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent |
| 04/20/2000 | WO2000021524A1 Pufa supplements |
| 04/20/2000 | WO2000021521A2 Sertraline oral concentrate |
| 04/20/2000 | WO2000021520A2 Opioid analgesic |
| 04/20/2000 | WO2000003004A3 Presenilin 2 specific ribozyme |
| 04/20/2000 | WO2000002519A3 Utilization of derivatives of tetrahydropyridines (or 4-hydroxypiperidines)-butylazols in the preparation of a medicament for the treatment of pain |
| 04/20/2000 | WO2000001440A3 Methods for treating neurological injuries and disorders |
| 04/20/2000 | WO1999065571A3 Use of optically pure (+)-norcisapride for treating apnea, bulimia and other disorders |
| 04/20/2000 | WO1999064000A9 Novel therapeutic agents that modulate neurokinin receptors |
| 04/20/2000 | WO1999054463A3 Human k+ ion channel and therapeutic applications thereof |
| 04/20/2000 | DE19847715A1 Treatment of schizophrenia symptoms without side effects, by transdermal administration of nicotine or its salt |
| 04/20/2000 | DE19847134A1 Treating withdrawal symptoms after addiction to alcohol or drugs, especially benzodiazepines, using kava extract |
| 04/20/2000 | DE19847064A1 Mutant AMPA-type glutamate receptor, useful for identifying receptor agonists and antagonists, lacks the desensitizing properties of the wild-type receptor |
| 04/20/2000 | DE19844836A1 Pharmazeutisch, wirksames, pflanzliches Präparat zur Behandlung von Migräne Pharmaceutical, effective, herbal preparation for the treatment of migraine |
| 04/20/2000 | CA2653503A1 The use of ara as a supplement for a lactating woman |
| 04/20/2000 | CA2347968A1 Follistatin-related protein zfsta2 |
| 04/20/2000 | CA2347653A1 Novel cell signaling polypeptides and nucleic acids |
| 04/20/2000 | CA2347225A1 Pharmaceutical formulations for use in estrogen deprivation syndrome |
| 04/20/2000 | CA2347192A1 Pharmaceutical combination of ibuprofen-lysine and domperidone for treating migraine |
| 04/20/2000 | CA2346776A1 Non-desensitizing ampa-receptors |
| 04/20/2000 | CA2346729A1 Ureidopiperidine derivatives as selective human nk3 receptor antagonists |
| 04/20/2000 | CA2346693A1 Pregnane glucuronides |
| 04/20/2000 | CA2346689A1 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents) |
| 04/20/2000 | CA2346542A1 Imidazo-benzazepines having cardiovascular, antitumor, antiinfective and antiinflammatory activity |
| 04/20/2000 | CA2346414A1 Imidazo-isoquinoline compounds, their compositions and uses |
| 04/20/2000 | CA2346155A1 Enzymatic synthesis of ssdna |
| 04/20/2000 | CA2344465A1 Methods and compositions for inhibiting neoplastic cell growth |
| 04/19/2000 | EP0994110A1 Sulphonamide derivatives |
| 04/19/2000 | EP0994107A1 5-Arylisoxazol-4-yl-substituted 2-amino carboxylic acid compounds |
| 04/19/2000 | EP0994102A1 Cyclic derivatives with a cycloalkylenic chain, process for their preparation and pharmaceutical compositions containing them |
| 04/19/2000 | EP0993613A2 Method for recognizing and determining gnrh receptors and the use of gnrh agonists and gnrh antagonists and other gnrh receptor ligands for the treatment with gnrh receptors of tumours originating in the brain and/or nervous system and/or meninges and/or of kaposi sarcoma |
| 04/19/2000 | EP0993461A1 New quinoxaline dione derivatives, the production thereof and use of the same in medicaments |
| 04/19/2000 | EP0993458A1 3-benzylpiperidine |
| 04/19/2000 | EP0993457A1 Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists |
| 04/19/2000 | EP0993450A1 New compounds |
| 04/19/2000 | EP0993449A1 Quinoline derivatives as pde iv and/or tnf inhibitors |
| 04/19/2000 | EP0993439A1 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as mek inhibitors |
| 04/19/2000 | EP0993437A1 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as mek inhibitors |
| 04/19/2000 | EP0993436A1 (S) 2-METHYLAMINO-2-PHENYL-$i(n)-BUTYL 3,4,5-TRIMETHOXYBENZOATE, ITS APPLICATION TO THE TREATMENT OF CHRONIC PAIN |
| 04/19/2000 | EP0993301A1 Cocaine receptor binding ligands |
| 04/19/2000 | EP0993299A1 N-oxides of heterocyclic esters, amides, thioesters, and ketones |
| 04/19/2000 | EP0880524B1 Adenosin antagonists, method of preparing them and their use as drugs |
| 04/19/2000 | EP0738262B1 Novel heterocyclic compounds |
| 04/19/2000 | EP0686144B1 New compounds |
| 04/19/2000 | CN1251134A Neurotrophic factor NNT-1 |
| 04/19/2000 | CN1251132A Variants of ciliary neurotrophic factor with enhanced receptor selectivity and method for their selection |
| 04/19/2000 | CN1251105A 2,3-dihydrofuro [3,2-b] pyridin, prepn. and application thereof of therapy |
| 04/19/2000 | CN1251100A Method for making arylamino triazolopyridines |
| 04/19/2000 | CN1251099A Thiazole benzenesulfonamides as beta 3 agoniste for treatment of diabetes and obesity |
| 04/19/2000 | CN1250771A Novel cyclocompound having cycloalkylene chain, prepn. method and pharmaceutical compositions contg. same |
| 04/19/2000 | CN1051558C Anthracyclie derivatives, prepn. method and use thereof |
| 04/19/2000 | CN1051546C Novel 1,1-bis(heteroazolyl) alkane derivatives and their use as neuroprotective agents |
| 04/19/2000 | CN1051461C Medicine 'Zhengxiesan' for treating facial paralysis and its prepn. method |